This website is intended for Medical Professionals only. By using this site you confirm that you are a healthcare professional.

News
Tension-Free Vaginal Tape Found Effective ... Long-term results from a BJU International study indicate that ... (25 Feb 2018)
Antidepressants are more effective than ... Meta-analysis of 522 trials includes the largest amount of ... (20 Feb 2018)
High blood pressure limits protection to ... New research published in The Journal of Physiology sheds light ... (20 Feb 2018)
Volunteering, caring for grandchildren and ... Paid work, volunteering, caring for grandchildren and other ... (20 Feb 2018)
Can Cardiac Devices Be Hacked?     Medical devices, including cardiovascular implantable ... (20 Feb 2018)
Thursday, 08 February 2018 22:08

Re-Introducing an ‘Old’ Antibiotic May Help Fight Multi-Drug Resistant Bacteria Featured

Rate this item
(0 votes)

A new study indicates that the drug fosfomycin may be effective for treating multidrug-resistant bacterial infections. In most European countries, the oral formulation is only approved as a 3 gram single dose for the treatment of uncomplicated cystitis; however the Pharmacology Research & Perspectives study found that a dosing regimen of 6–12 grams per day divided in 3 doses is required for the treatment of systemic multi-drug-resistant bacterial infections.

Fosfomycin—an ‘old’ antibiotic that was developed more than 40 years ago—is a broad spectrum antibiotic that inhibits the early stages of the bacterial cell wall synthesis.

“Importantly, we show that there is a viable alternative to the lengthy and thus costly development of new antibiotics. The often scattered knowledge in literature and in the clinic is waiting to be combined and can be used immediately in a confirmatory clinical trial,” said senior author Dr. Jasper Stevens, of the University Medical Center Groningen, in The Netherlands.


Source: Wiley
Full bibliographic information:
Natalia V. Ortiz Zacaras, Anneke C. Dijkmans, Jacobus Burggraaf, Johan W. Mouton, Erik B. Wilms, Cees van Nieuwkoop, Daan J. Touw, Ingrid M. C. Kamerling and Jasper Stevens. Fosfomycin as a potential therapy for the treatment of systemic infections: a population pharmacokinetic model to simulate multiple dosing regimens. Pharmacology Research & Perspectives.

Read 97 times Last modified on Friday, 09 February 2018 18:29

TheSynapse Videos

0
0
0
0
0
0

Latest news

Highlights

SPONSOR MESSAGE

July 31, 2016
0

Join

Connect with other Medical Professionals on fb in a closed facebook group

Login

Template Settings

Theme Colors

Cyan Red Green Oranges Teal

Layout

Wide Boxed Framed Rounded
Patterns for Layour: Boxed, Framed, Rounded
Top
We use cookies to improve our website. By continuing to use this website, you are giving consent to cookies being used. More details…